As per NPPA Order S.O. 5690(E) dated 17 October 2026, the trade margin on 137 non-scheduled anti-cancer medicines is capped at 30%. Hetero’s revised MRPs take effect on 9 November 2026.
Patients and partners with questions about the revised prices are welcome to speak to their doctor, pharmacist or hospital.
Source: NPPA Order S.O. 5690(E), The Gazette of India, 17 October 2026.
Ornova Division focuses on delivering advanced therapeutic solutions for pain management, wound care, and transdermal drug delivery. Its diverse portfolio includes advanced therapies for pain relief, wound healing, and transdermal treatment, helping healthcare professionals deliver effective and personalised care. With a focus on innovation, quality, and patient-centred care, the division helps orthopaedic specialists, physiotherapists, anaesthesiologists, and other healthcare providers in achieving better treatment outcomes in pain and rehabilitation
View by-